PRINCETON, NJ – Feb. 14, 2018 – Certara today announced the launch of version 10 of D360, its data informatics platform for discovery scientists. D360 is a self-service data access, integration and visualization solution used to query diverse cheminformatics and bioinformatics data sources to make informed go/no go research decisions.
D360 Partner is an affordable add-on product for D360 for external partners that allows for seamless, secure sharing of data and analysis while advancing communication and collaboration.
PRINCETON, NJ – Aug. 10, 2017 – Certara today announced that it has added externalization technology to its D360 scientific informatics platform. The resulting new product, D360 Partner, facilitates collaboration between sponsors and their external research partners.
PRINCETON, NJ – Jan. 31, 2017 – Certara today announced that it has released D360 version 9.0 along with D360 Express, its data informatics platform for discovery scientists. D360 is a self-service data access, integration and visualization solution.
D360 Express is an out-of-the-box integrated solution specifically designed for discovery scientists at smaller pharmaceutical research organizations. It provides access, integration, analysis and visualization of scientific data from multiple data sources. D360 Express gets you up and running quickly and affordably.
Discovery drug research requires understanding complex biological, chemical, logistical and computational data from a wide variety of data sources. Certara’s D360 platform was specifically designed to meet the discovery researcher’s workflow needs.
PRINCETON, NJ – 2016年6月23日 – The D360 packaged informatics solution reduces research cycle time, delivering faster insights for busy discovery scientists.
D360 version 8.0 supports connections to broader and more diverse data sets, increases collaboration across silos, and delivers faster time to insight for scientific decision making PRINCETON, NJ – Feb. 17, 2015 – Certara®, the global biosimulation technology-enabled drug development and drug safety consulting company, today announced that it will be launching version 8.0 of … Continued
A recent report by Deloitte identified the #1 trend in the life sciences market as an increased focus on patient safety and enforcement. While it seems obvious to consider safety issues in approved drugs, regulatory agencies such as the FDA and EMA (European Medicines Agency) are extending their scrutiny to the entire drug development process, … Continued
User Group Meeting “Highly Informative and Incredibly Valuable,” Says D360 Clients ST. LOUIS, MO – Oct. 17, 2014 – Certara’s Second Annual D360™ User Group Meeting (UGM) was described as “Highly Informative” and “Incredibly Valuable” by top pharmaceutical scientists who attended. The meeting, held at the Boston’s Royal Sonesta Hotel on October 8 and 9, … Continued
